Parkinson's Progress: Some Neurons Are Responsible for Starting and Stopping of Actions

New work uncovers neurons that start and end an action

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Patients with Parkinson’s disease often have trouble with walking. Either they cannot take the first step, or they cannot stop moving when they reach their destination. The problem is not with the steps themselves but with starting and stopping the action—a pervasive difficulty that affects every aspect of daily life. Now research has finally pinpointed the neurons in the brain that initiate and end movements.

Rui Costa of the Champalimaud Neuroscience Program in Portugal and Xin Jin of the National Institutes of Health designed a task for mice that was the equivalent of taking eight steps. If the mice pressed a bar exactly eight times, no more, no less, they received a reward. Costa and Jin implanted tiny electrodes in each mouse’s brain to record the ac­tivity of neurons within the striatum, a structure deep in the brain known to be involved in motor commands. They found that some neurons became active right before the mouse started to press the bar and other neurons became active right before stopping.

To confirm that these neurons were indeed responsible for starts and stops, the researchers then genetically altered mice to lack the neurons, and subse­quently the mice could not learn the task. They were slow to begin pressing the bar, and they tended to randomly stop in the middle of the task. These mice did not have trouble with movements per se, Costa explains, but like people with Parkinson’s or Huntington’s disease, with starting and stopping a task properly. The work should help scientists under­stand precisely what goes wrong in the brains of patients and help them design better therapies, Costa says.

Carrie Arnold is an independent public health journalist in Virginia.

More by Carrie Arnold
SA Mind Vol 21 Issue 5This article was published with the title “Stop and Go” in SA Mind Vol. 21 No. 5 (), p. 13
doi:10.1038/scientificamericanmind1110-13a

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe